Researchers have been excited about the medication , a groundbreaking dual compound showing promising results in clinical trials for weight loss . It acts by targeting both systems: GLP-1 and GIP, https://montyfrbm529899.activoblog.com/51418546/this-new-hope-for-weight-reduction